navlowban

Investor Relations

arrow Overview

arrow Investment Highlights

arrow FAQ

arrow Stock Quote

arrow News Releases

arrow SEC Filings

arrow Analyst Coverage

arrow Webcasts

arrow CFMI (PPT) Presentation

arrow Standard & Poor’s

arrow Email Alerts & IR Contact

investor relations

Investment Highlights

  • Large & Expanding Pharmaceutical Market in China
  • Nation-wide Distribution Network
  • Prescription & OTC
  • Western & Traditional Chinese Medicines (TCM)
  • Low Cost Advantage
  • Experienced Management team employing aggressive growth strategy
  • Very strong Balance Sheet - strong cash and working capital combined with no long term debt
  • Strong Financial Performance - consistent annual growth

Financial Snapshot: March 31, 2011

Balance Sheet

 

Cash

$9.5m

 

 

Working Capital

$24.1m

 

 

Total Assets

$48.1m

 

 

Long Term Debt

Nil

 

 

Net Worth

$45.6m

 

 

Shares Outstanding

12,539,662

 

 

Market Capitalization

$64.0m

 

 

Current Price*

$5.10 (3/31/2011)

 

 

Financial Performance

Selected Income Statement Items

 

 

 

 

 

 

$mm FYE 12/31

 

 

 

 

 

 

 

 

 

2006

 

2007

 

2008

 

2009

 

2010

Revenues

 $ 4.9

 

 $  10.5

 

 $  18.2

 

 $  26.7

 

 $  34.2

   y-o-y growth

 

 

111.4%

 

73.8%

 

47.0%

 

28.1%

 

 

 

 

 

 

 

 

 

 

EBITDA

   1.9

 

4.3

 

9.6

 

11.7

 

11.2

   y-o-y growth

 

121.3%

 

126.6%

 

21.7%

 

-4.2%

 

 

 

 

 

 

 

 

 

 

EBITDA Margin

38.9%

 

40.7%

 

53.0%

 

43.9%

 

32.7%

 

 

 

 

 

 

 

 

 

 

   EBIT

   1.6

 

3.8

 

    9.0

 

10.9

 

10.4

      Margin

31.9%

 

36.5%

 

49.5%

 

40.9%

 

30.4%

 

 

 

 

 

 

 

 

 

 

Net Income

 $ 1.3

 

 $   3.5

 

 $   7.3

 

 $   8.9

 

 $   8.4

      Margin

26.0%

 

33.5%

 

40.4%

 

33.4%

 

24.6%

 

 

 

 

 

 

 

 

 

 

   Diluted EPS

 

 

 

 

 $  0.84

 

 $  0.95

 

 $  0.75

Home  |  Profile |  Management  |  Products  |  Investor Relations  |  Contact  Site Map  |   Privacy Policy  |  Disclaimer   |  FAQ

 logo sm2   Copyright © 2011 China Pharmaceuticals, Inc. All rights reserved. Tel: 86-29-8406-7215  OTCBB Listed CFMI